Circulating oxylipins predict mortality in heart failure with preserved ejection fraction. [PDF]
Ali Z, Anwar M, Subhani W, Kirmani SA.
europepmc +1 more source
Heart Failure with Preserved Ejection Fraction as a Multisystem Syndrome: A Mechanistically Anchored Endotype Framework for Precision Therapy. [PDF]
Krasińska B +2 more
europepmc +1 more source
Heart failure with preserved ejection fraction beyond the heart: exploring the heart-liver-pancreas axis. [PDF]
Tun HN +4 more
europepmc +1 more source
Polyphenols as Adjuvant Treatment for Heart Failure with Preserved Ejection Fraction (HFpEF): A Review. [PDF]
Medeiros SGF +8 more
europepmc +1 more source
Calcium Channel Blockade Versus β-Blockade for Hypertension in Heart Failure With Preserved Ejection Fraction: A Randomized Crossover Trial. [PDF]
Cohen JB +12 more
europepmc +1 more source
Sex and Atrial Fibrillation Independently Stratify Cardiac Remodeling and Outcomes in Heart Failure with Preserved Ejection Fraction. [PDF]
Hădăreanu DR +11 more
europepmc +1 more source
Response to the letter to the editor: Epicardial, visceral and subcutaneous adipose tissue in heart failure with preserved ejection fraction. [PDF]
Lobeek M +3 more
europepmc +1 more source
Machine Learning Applications for Risk Stratification in Heart Failure with Preserved Ejection Fraction: A New Era in Cardiology. [PDF]
Rajab BS.
europepmc +1 more source
Hyaluronan and Syndecan-1: Linking Glycocalyx Degradation to Development and Progression of Heart Failure With Preserved Ejection Fraction. [PDF]
Rocha-Oliveira E +13 more
europepmc +1 more source
Targeting epicardial adipose tissue in heart failure with preserved ejection fraction: exploring the dapagliflozin connection. [PDF]
Soliman AM +4 more
europepmc +1 more source

